Researcher Next
Create account
← Back to directory

Helen Gogas

Researcher Next ID · RN-009739

Researcher · Biochemistry, Genetics and Molecular Biology

National and Kapodistrian University of Athens

, Greece

Sign in to saveSign in to claim
Not currently recruitingFunding unknown
Works count
603
Citation count
35,501
H-index
75
i10-index
289

Research interests

Biochemistry, Genetics and Molecular Biology
Medicine
Immunology and Microbiology
Melanoma and MAPK Pathways
Cancer Immunotherapy and Biomarkers
Cutaneous Melanoma Detection and Management
CAR-T cell therapy research
Immunotherapy and Immune Responses

Publications

  • Five-Year Outcomes with Dabrafenib plus Trametinib in Metastatic Melanoma

    New England Journal of Medicine · 2019 · 10.1056/nejmoa1904059

  • Adjuvant Nivolumab versus Ipilimumab in Resected Stage III or IV Melanoma

    New England Journal of Medicine · 2017 · 10.1056/nejmoa1709030

  • Dabrafenib and trametinib versus dabrafenib and placebo for Val600 BRAF-mutant melanoma: a multicentre, double-blind, phase 3 randomised controlled trial

    The Lancet · 2015 · 10.1016/s0140-6736(15)60898-4

  • Nivolumab in Previously Untreated Melanoma without BRAF Mutation

    New England Journal of Medicine · 2014 · 10.1056/nejmoa1412082

  • Combined BRAF and MEK Inhibition versus BRAF Inhibition Alone in Melanoma

    New England Journal of Medicine · 2014 · 10.1056/nejmoa1406037

Current projects

    No projects listed.